Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains

International Journal of Developmental Neuroscience

Volumn 18, Issue 8, 2000, Pages 807-813

  Durany, Nuria ^a,b   Michel, Tanya ^a   Kurt, Jellinger ^c   Cruz Sánchez, Felix F ^b   Cervós Navarro, Jorge ^b   Riederer, Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

^c INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

Author keywords

Alzheimer's disease; Brain derived neurotrophic factor; Cholinergic neurones; ELISA; Neurotrophin 3; Post mortem brain

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3;

ADOLESCENT; ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN; CHILD; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOREBRAIN; GENDER; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; PARIETAL LOBE; PRIORITY JOURNAL; PUTAMEN;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHOLINERGIC FIBERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; NEUROTROPHIN 3; POSTMORTEM CHANGES; PUTAMEN; SEX FACTORS;

EID: 0034520301     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(00)00046-0     Document Type: Article

References (32)

1. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurones in culture
2. Characterization and topography of high affinity 125I-neurotrophin-3 binding to mammalian brain
3. A unifing hypothesis for the cause of amytrophic lateral sclerosis, parkinsonism, and Alzheimer's disease
4. Degeneration of rat cholinergic basal forebrain neurons and reactive changes in nerve growth factor expression after chronic neurotoxic injury-I. Degeneration and plastic response of basal forebrain neurons
5. Degeneration of rat cholinergic basal forebrain neurons and reactive changes in nerve growth factor expression after chronic neurotoxic injury-II. Reactive expression of the nerve growth factor gene in astrocytes
6. Dentritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Lorsakoff′s disease, Parkinson's disease, and Alzheimer's disease
7. Dentritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas
8. Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain
9. Neurotrophic factors and their receptors
10. Brain-derived neurotrophic factor is reduced in Alzheimer's disease
11. Detection of NGF like activity in human brain tissue; increased levels in Alzheimer's disease
12. How to run a brain bank. A report from the Austro-German brain bank
13. Neurotrophic factor therapy for nervous system degenerative diseases
14. NGF content in the cerebral coertex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease
15. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain
16. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF
17. The neuropathological diagnosis of Alzheimer's disease
18. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates
19. Alzheimer's disease: a cell biological perspective
20. Neurotrophic factors: from molecule to man
21. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma
22. Protein measurement with folio phenol reagent
23. NT-3, BDNF and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression
24. NGF level is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease
25. Neurotrophin-3 (NT-3) levels in the developing rat nervous system and in human samples
26. Differential regulation of brain-derived neurotrophic factor and tyepe II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimers disease
27. Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease
28. Differential regulation of hippocampal neurotrophins during aging in rats
29. Basal forebrain cholinergic system: a functional analysis
30. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
31. Neurotrophins and neuronal plasticity